Distribution of Candida species isolated from blood cultures in a university hospital
Amaç: Kandidemi, nozokomiyal kan dolaşımı enfeksi- yonları arasında dördüncü sırada yer almaktadır. İnvaziv kandidiyazda Candida albicans halen en sık tanımlanan patojen olsa da, albicans dışı kandida türlerine bağlı en- feksiyonlarda dramatik artış dikkati çekmektedir bu du- rum, klinik uygulamadaki değişimleri yansıtmaktadır. Bu çalışmanın temel amacı kandidemi etkeni Candida türle- rinin hastanemizdeki dağılımını belirleyerek hastane en- feksiyonlarının önlenmesine katkıda bulunmaktır. Yöntemler: Retrospektif (2013-2014) bu çalışmada kan kültürlerinden izole edilen Candida türlerinin epidemiyo- lojik, klinik ve mikrobiyolojik karakteristikleri bildirilmiştir. Bulgular: Toplam 200 Candida spp türü %38 C. albicans, %24,5 C. parapsilosis, %16,5 C. tropicalis, %13 C. glab- rata, %3 C. krusei, %2 C. sake, %1 C. lusitaniae, %0,5 C. guilliermondii olarak tanımlanmıştır. Tanımlanan Candida türleri en yüksek oranla (103/200; %51,5) yoğun bakım ünitesinde saptanmıştır. Sonuç: Candida infeksiyonları için risk teşkil eden hasta popülasyonunun artmasına paralel olarak, türlerin tanım- lanması ve etkin tedavi protokollerinin geliştirilmesi için epidemiyolojik çalışmaların yapılması gerekmektedir.
Bir üniversite hastanesinde kan kültürlerinden izole edilen Candida türlerinin dağılımı
Objective: Candidemia is the fourth most common infec- tion among nosocomial blood circulation infections. Al- though Candida albicans is the most frequently identified species in invasive candidiasis, incidence of non-albicans Candida species were increased especially among criti- cally ill patients. This reflects the changes in clinical prac- tice. The main objective of the present study is to deter- mine the distribution of the Candida species that causes candidemia in our hospital and contributes to the preven- tion of nosocomial infections. Methods: In a retrospective study (2013-2014) on candi- demia, various Candida species isolated from blood cul- tures were evaluated and their epidemiological, clinical, and microbiological characteristics were determined. Results: A total of 200 species of Candida were iden- tified and the distribution was as follows: 38% C. albi- cans, 24.5% C. parapsilosis, 16.5% C. tropicalis, 13% C. glabrata, 3% C. krusei, 2% C. sake, 1% C. lusitaniae, 0.5% C. guilliermondii. The highest amounts of (103/200; 51.5%) of Candida species were identified at the adult intensive care unit. Conclusion: Parallel to the increase in the patient popu- lation that is as risk for Candida infections, epidemiologi- cal studies should be made to identify the species and develop effective treatment protocols.
___
- 1. Hidron AI, Edwards JR, Patel J, et al. NSHN annual up- date: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. In- fect Control Hosp Epidemiol 2008;29:996-1011. 2. Kett DH, Azoulay E, Echeverria PM, Vincent JL. Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. Crit Care Med 2011;39:665-670. 3. Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;39:309-317. 4. Guo F, Yang Y, Kang Y, et al. Invasive candidiasis in inten- sive care units in China: a multicentre prospective observa- tional study. J Antimicrob Chemother 2013;68:1660-1668. 5. Ells R, Kock JLF, Pohl CH. Candida albicans or Candida dubliniensis? Mycoses 2011;54:1-16. 6. Wey SB, Mori M, Pfaller MA, et al. Hospital acquired can- didemia: The attributable mortality and excess lengthy of stay. Arch Intern Med 1988;148:2642-2645. 7. Chen LY, Yang SP, Chen TL, et al. Clinical significance of time to positivity for yeast in candidemia. J Microbiol Im- munol Infect 2015;48:425-430. 8. Ma CF, Li FQ, Shi LN, et al. Surveillance study of spe- cies distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China. BMC Infect Dis 2013;13:337. 9. Bouza E, Muñoz P. Epidemiology of candidemia in intensive care units. Int J Antimicrob Agents 2008;32(Suppl 2):87- 91. 10. Ruan SY, Lee LN, Jerng JS, et al. Candida glabrata fun- gaemia in intensive care units. Clin Microbiol Infect 2008;14:136-140. 11. Montagna MT, Lovero G, Borghi E, et al. Candidemia in intensive care unit: a nationwide prospective observational survey (GISIA-3 study) and review of the European litera- ture from 2000 through 2013. Eur Rev Med Pharmacol Sci 2014;18:661-674. 12. Meyer E, Geffer C, Gastmeier P, Schwab F. No increase in primary nosocomial candidemia in 682 German in- tensive care units during 2006 to 2011. Euro Surveill 2013;18:20505. 13. Nawrot U, Pajaczkowska M, Fleischer M, et al. Candidae- mia in polish hospitals - a multicentre survey. Mycoses 2013;56:576-581. 14. Bergamasco MD, Garnica M, Colombo AL, Nucci M. Epidemiology of candidemia in patients with hemato- logic malignancies and solid tumours in Brazil. Mycoses 2013;56:256-263. 15. Çalışkan E, Dede A, Biten Güven G. Distribution and an- tifungal susceptibilities of Candida species isolated from blood cultures. Ankem 2013;27:25-30. 16. Atalay MA, Sav H, Demir G, Koç AN. Distribution of can- dida species ısolated from blood cultures and in-vitro sus- ceptibilities to Amphotericin b and Fluconazole. Medical Journal of Selçuk 2012;28:149-151. 17. Gültekin B, Eyigör M, Telli M, et al. A Retrospective Inves- tigation of Candida Species Isolated from Blood Cultures during a seven-year period. Ankem 2010;24:202-208. 18. Aslan U, Uysal EB, Işık F, et al. Candida species isolated in blood samples, 2002-2005 İnfeksiyon Derg 2006;20:177- 181. 19. Yenigün Koçak B, Kuloğlu F, Doğan Çelik A, Akata F. Evaluation of Epidemiological Characteristics and Risk Factors of Candidemia in Adult Patients in a Tertiary-Care Hospital. Mikrobiyol Bul 2011;45:489-503. 20. Yapar N, Pullukcu H, Avkan-Oguz V, et al. Evaluation of species distribution and risk factors of candidemia: a multi- center case-control study. Med Mycol 2011;49:26-31